[
  {
    "ts": "2025-10-03T11:40:08+00:00",
    "headline": "Is Global Expansion of LEQEMBI Enough to Reinforce Biogen’s (BIIB) Long-Term Pipeline Strength?",
    "summary": "Eisai Co., Ltd. and Biogen Inc. recently announced that Australia’s Therapeutic Goods Administration approved LEQEMBI (lecanemab) for use in adults with mild cognitive impairment or mild dementia due to Alzheimer’s disease, supported by positive Phase 3 Clarity AD trial data. This marks another key regulatory milestone that expands LEQEMBI’s international reach, as new dosing options gain approval in countries including China and the US, potentially making Alzheimer’s treatment more...",
    "url": "https://finance.yahoo.com/news/global-expansion-leqembi-enough-reinforce-114008297.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ff6fd984-180c-3ac4-baf7-2f21ed1f6854",
      "content": {
        "id": "ff6fd984-180c-3ac4-baf7-2f21ed1f6854",
        "contentType": "STORY",
        "title": "Is Global Expansion of LEQEMBI Enough to Reinforce Biogen’s (BIIB) Long-Term Pipeline Strength?",
        "description": "",
        "summary": "Eisai Co., Ltd. and Biogen Inc. recently announced that Australia’s Therapeutic Goods Administration approved LEQEMBI (lecanemab) for use in adults with mild cognitive impairment or mild dementia due to Alzheimer’s disease, supported by positive Phase 3 Clarity AD trial data. This marks another key regulatory milestone that expands LEQEMBI’s international reach, as new dosing options gain approval in countries including China and the US, potentially making Alzheimer’s treatment more...",
        "pubDate": "2025-10-03T11:40:08Z",
        "displayTime": "2025-10-03T11:40:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/I2k3PKJsWIEX9xgEQz8JwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tmSjpFKmBAT61w1lG5.BLQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/global-expansion-leqembi-enough-reinforce-114008297.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/global-expansion-leqembi-enough-reinforce-114008297.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "4523.T"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]